QMoat Research
Evidence-led company analysis for patient, long-term investors.
Latest research
RELX’s risk isn’t losing authority; it’s losing the front door. If AI chatbots become the default interface, RELX may be reduced to back-end data—useful, but priced like a utility.
Broadcom’s latest earnings update showed AI demand accelerating at a breathtaking pace—but also revealed the trade-offs that come with scale. As custom accelerators and rack-level systems take a larger share of revenue, margins are under pressure even as backlog and cash flow surge. The quarter underscored a deeper shift in the AI economy: from a race for chips to a battle over who controls the infrastructure that makes large-scale intelligence possible.
Venture-backed challengers are reshaping the modern HR stack with sleek interfaces and global workflows, but the payroll industry’s old guard isn’t fading quietly. ADP and Paychex remain anchored by regulatory muscle, switching-cost moats and newly rebuilt cloud platforms, creating a competitive landscape defined less by sudden disruption than by a slow, grinding rebalancing of who powers America’s paychecks.
Latest research
Align Technology ended the year with a rare combination: record Invisalign shipments, improving profitability, and a steadier tone from management. The catch is familiar—average revenue per case is still drifting down as growth tilts toward lower-priced markets and heavier discounts, forcing the company to prove it can expand margins through productivity, not pricing power.
Zoetis shares plunged after a rare growth wobble in its pet-health franchise. But with margins intact and valuations reset, the selloff looks more like the end of a perfection trade than a structural break—raising the question: is this the moment to buy?
If giredestrant can secure a broad label and embed itself in treatment guidelines as a preferred endocrine partner, it would reinforce Roche’s franchise in breast cancer and create a recurring revenue stream with unusually high duration
Latest research
Costco’s September 24 results show why sharing gains with customers can strengthen a competitive moat. The lesson for investors is to separate durable economics from one-off profits—and business quality from the price paid.
Deckers Outdoor’s stock stumbled despite solid Q3 results and resilient Hoka growth. With tariffs clouding guidance but free cash flow strong, the selloff looks overdone. At this valuation, the post-earnings drop offers long-term investors a rare entry point.
After years of inflation-fueled price hikes, Europe’s bake-off industry faces tighter margins and fiercer retailer negotiations. With input costs easing, growth now depends on volume, mix, and efficiency rather than pricing power.
Latest research
Insurify’s AI comparison app fuels fears of broker disruption. Here’s what’s truly at risk—and why Marsh, Aon and AJG may adapt and defend.
At its Investor Day in London on Friday, Swiss Re delivered a message that mixed confidence with caution: the reinsurance giant believes it has entered 2026 with one of the strongest portfolio positions in years, yet its leadership is visibly intent on avoiding the complacency that has tripped up the industry in past cycles.
Latest research
Cintas is growing strongly before its $5.5 billion acquisition closes. But UniFirst’s advertised eight-times EBITDA price includes $375 million of savings still to be earned—and Cintas shares trade at more than 36 times expected earnings.
Linde quietly dominates industrial gases with dense networks, proprietary engineering and long-term take-or-pay contracts that pass through energy costs, keeping cash flows steady.
SIG’s shopping spree—Scholle IPN and Evergreen—blurred its aseptic razor-blade edge, lifted leverage, and squeezed margins. The reset hands Ola Rollén a clear brief: prune the commodity pieces, migrate what’s upgradeable to aseptic economics, and rebuild the core duopoly story.
Latest research
EPAM Systems unveiled a $1 billion share repurchase—roughly equal to its entire cash reserve. The bold move signals management’s conviction that the market undervalues the digital-engineering specialist’s long-term prospects.
Marsh McLennan’s stock is down, but secular growth drivers remain. Can the risk-adviser giant still deliver for long-term investors?
Latest research
Most investors can name Buffett or Terry Smith. But a quieter elite of “quality purists” has been compounding capital far from the spotlight — from Montréal to Hong Kong, from Zurich to London. They buy great businesses, hold them for years, and let time do the heavy lifting.
After years of dominance, the quality factor has stumbled since mid-2024 as markets chased risk and valuations stretched. Narrow leadership and speculative fervor left steady earners behind—but shifting tides could soon restore quality’s quiet strength.
Normalize patents by population and the leaderboard flips. A small cadre of export-driven, research-heavy economies consistently turn lab work into defensible products—via tight lab-to-factory loops, patient capital, and standards savvy.
Latest research
For Marsh, Aon, WTW and Gallagher, AI looks less like a guillotine than a lever—stripping costs from placements, sharpening advisory clout, and spawning new insurable risks—even as it pressures small-ticket business. The winners weld data, governance and speed into advantage.
From IKEA to Spotify, Sweden keeps turning its modest size into a factory of world-class firms. The secret lies in long-term ownership, digital infrastructure, and a culture where ambition, trust, and design discipline quietly compound into global scale.
AI inference has turned data centers into industrial-scale factories, built on dense accelerators, high-bandwidth memory, liquid cooling and optical fabrics. The race to serve tokens efficiently is reshaping supply chains from GPUs to fiber switches.
Latest research
Investors are trained to admire fast top lines. In buoyant markets, momentum plus a large total addressable market can mesmerize. But not all growth creates value.
Every market cycle produces stocks that look irresistibly cheap and then refuse to go anywhere. The “value trap” is the classic case: a low multiple that masks eroding economics, overstated assets or fragile balance sheets. Screening for single-digit P/Es or high dividend yields can be a useful starting point, but it is also how many investors get caught.
A good income statement tells a simple story: how a company turns revenue into profit over a defined period. The trick is to separate narrative from noise quickly. In 10 minutes, you can triage three questions that matter most for investors and operators alike: is growth real, are margins defensible, and is profit repeatable on a per-share basis?
QMoat Research System
Compare companies across financial strength, durable competitive advantages and governance.
Independent quality-investing research and new score updates, delivered with discipline.
By confirming, you agree to receive the QMoat newsletter. Unsubscribe anytime with the private link in each email.
